Rx only · Injection · Intravenous

Sodium Acetate

Sodium Acetate Anhydrous

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US3 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCB05XA08

RxCUI (US)56443

US makers1 labelers

Packages3

DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Rx · 2026 Q1

23K

Units dispensed

Quarters · since 2025 Q4

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Hikma Pharmaceuticals USA Inc.	unknown	3	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Feb 3, 2016
SHORTAGEDrug shortage: Sodium Acetate Injection (Hikma Pharmaceuticals USA, Inc.)
Sodium Acetate Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition.